Global Anti-hypertensive Drug Market Size To Exceed USD 50 Billion By 2033 | CAGR of 7.18% [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
to Reach USD 50 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Abbott Laboratories, AstraZeneca Plc., Dr. Reddy's Laboratories, Sanofi, Johnson & Johnson Services Inc., Pfizer Inc., Merck & Co. Inc., Medtronic Inc., GlaxoSmithKline Plc., Stryker Corporation, Orthofix, Takeda Pharmaceutical Co., Bayer AG, Noden Pharma DAC, and Others New York, United States, April 18, 2024 (GLOBE NEWSWIRE) -- The Global Anti-hypertensive Drug Market Size is to Grow from USD 25 Billion in 2023 to USD 50 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 7.18% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/3938 Hypertension is a long-term medical condition that involves persistent elevation of arterial blood pressure. According to the estimates, hypertension is the major cause of premature death worldwide. The consumption of unhealthy diets, physical inactivity, tobac
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson proposes to pay $6.5B to settle talc ovarian cancer lawsuits in US [FOX Business Network]FOX Business Network
- HANNA ANDERSSON APPOINTS FORMER APPLE, GAP MARKETING EXECUTIVE GRACE WONG AS CHIEF BRAND OFFICER [Yahoo! Finance]Yahoo! Finance
- In The Far West Village Of NYC, Hungry Llama Is Attracting A Clientele [Forbes]Forbes
- Beasley Allen Law Firm: Attorneys for Women Harmed by Johnson & Johnson's Talcum Powder Resist Company's Attempt to Stuff Ballot Box in Unprecedented Third Attempted Bankruptcy [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn's disease [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/29/24 - Form 4
- JNJ's page on the SEC website